Avanos Medical reports Q3 mixed earnings; reaffirms FY22 guidance

Nov. 02, 2022 7:16 AM ETAvanos Medical, Inc. (AVNS)By: Meghavi Singh, SA News Editor
  • Avanos Medical press release (NYSE:AVNS): Q3 Non-GAAP EPS of $0.38 beats by $0.03.
  • Revenue of $202M (+9.7% Y/Y) misses by $3.47M.
  • Adjusted gross margin was 56 percent, compared to 52 percent last year.
  • Free cash flow for the quarter was $23M, compared

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.